(3) The effects of the Parkinson's disease inducing neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, which targets complex I in the electron transport chain can be suppressed by providing recombinant Tat-Fxn (70). The gene discussed is TAT; the disease is Parkinson disease.